{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:18:37Z","timestamp":1774880317480,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82172800"],"award-info":[{"award-number":["No. 82172800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["No. 2020Y9125"],"award-info":[{"award-number":["No. 2020Y9125"]}]},{"name":"Talent programs granted from The First Affiliated Hospital of Fujian Medical University","award":["YJRC3600"],"award-info":[{"award-number":["YJRC3600"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s13304-024-01869-5","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T07:02:09Z","timestamp":1715324529000},"page":"2163-2171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Conditional survival nomogram for patients with colon mucinous adenocarcinoma to predict prognosis: a dynamic survival analysis"],"prefix":"10.1007","volume":"76","author":[{"given":"Huajun","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"1869_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"1869_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A et al (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70:145\u2013164","journal-title":"CA Cancer J Clin"},{"key":"1869_CR3","doi-asserted-by":"crossref","unstructured":"O'Connell E, Reynolds IS, McNamara DA et al (2021) Resistance to cell death in mucinous colorectal cancer\u2014a review. Cancers (Basel) 13:1389","DOI":"10.3390\/cancers13061389"},{"key":"1869_CR4","first-page":"13","volume":"39","author":"C Luo","year":"2019","unstructured":"Luo C, Cen S, Ding G, Wu W (2019) Mucinous colorectal adenocarcinoma: clinical pathology and treatment options. Cancer Commun (Lond) 39:13","journal-title":"Cancer Commun (Lond)"},{"key":"1869_CR5","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1002\/cam4.2234","volume":"8","author":"C Li","year":"2019","unstructured":"Li C, Zheng H, Jia H et al (2019) Prognosis of three histological subtypes of colorectal adenocarcinoma: a retrospective analysis of 8005 Chinese patients. Cancer Med 8:3411\u20133419","journal-title":"Cancer Med"},{"key":"1869_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrclinonc.2015.140","volume":"13","author":"N Hugen","year":"2016","unstructured":"Hugen N, Brown G, Glynne-Jones R et al (2016) Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol 13:361\u2013369","journal-title":"Nat Rev Clin Oncol"},{"key":"1869_CR7","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.clcc.2021.06.004","volume":"20","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xie X, Wu Z et al (2021) Mucinous adenocarcinoma predicts poor response and prognosis in patients with locally advanced rectal cancer: a pooled analysis of individual participant data from 3 prospective studies. Clin Colorectal Cancer 20:e240\u2013e248","journal-title":"Clin Colorectal Cancer"},{"key":"1869_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00432-019-03077-w","volume":"146","author":"V Catalano","year":"2020","unstructured":"Catalano V, Bergamo F, Cremolini C et al (2020) Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients. J Cancer Res Clin Oncol 146:493\u2013501","journal-title":"J Cancer Res Clin Oncol"},{"key":"1869_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/DCR.0000000000001022","volume":"61","author":"M Kanda","year":"2018","unstructured":"Kanda M, Oba K, Aoyama T et al (2018) Clinical signatures of mucinous and poorly differentiated subtypes of colorectal adenocarcinomas by a propensity score analysis of an independent patient database from three phase III trials. Dis Colon Rectum 61:461\u2013471","journal-title":"Dis Colon Rectum"},{"key":"1869_CR10","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.2010.32.4343","volume":"29","author":"MY Polley","year":"2011","unstructured":"Polley MY, Lamborn KR, Chang SM et al (2011) Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 29:4175\u20134180","journal-title":"J Clin Oncol"},{"key":"1869_CR11","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1002\/cncr.31160","volume":"124","author":"P Wang","year":"2018","unstructured":"Wang P, Sun Z, Wang W et al (2018) Conditional survival of patients with gastric cancer who undergo curative resection: a multi-institutional analysis in China. Cancer 124:916\u2013924","journal-title":"Cancer"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1245\/s10434-021-09629-0","volume":"28","author":"A Ejaz","year":"2021","unstructured":"Ejaz A, Pawlik TM (2021) Conditional recurrence-free survival for patients with gallbladder cancer: a personalized resource for patients and providers. Ann Surg Oncol 28:2436\u20132437","journal-title":"Ann Surg Oncol"},{"key":"1869_CR13","doi-asserted-by":"crossref","unstructured":"Shah MM, Meyer BI, Rhee K et al (2020) Conditional survival analysis of hepatocellular carcinoma. J Surg Oncol 122:684-690","DOI":"10.1002\/jso.26049"},{"key":"1869_CR14","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.21037\/jgo-21-824","volume":"12","author":"L Lian","year":"2021","unstructured":"Lian L, Xu XF, Shen XM et al (2021) Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis. J Gastrointest Oncol 12:2906\u20132918","journal-title":"J Gastrointest Oncol"},{"key":"1869_CR15","first-page":"6594","volume":"18","author":"D Dai","year":"2019","unstructured":"Dai D, Zhou B, Zhong Y et al (2019) Survival of patients with resected primary colorectal mucinous adenocarcinoma: a competing risk nomogram analysis. Oncol Lett 18:6594\u20136604","journal-title":"Oncol Lett"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1200\/JCO.2003.04.521","volume":"21","author":"H Skuladottir","year":"2003","unstructured":"Skuladottir H, Olsen JH (2003) Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 21:3035\u20133040","journal-title":"J Clin Oncol"},{"key":"1869_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10120-007-0424-9","volume":"10","author":"SJ Wang","year":"2007","unstructured":"Wang SJ, Emery R, Fuller CD et al (2007) Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10:153\u2013158","journal-title":"Gastric Cancer"},{"key":"1869_CR18","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1245\/s10434-012-2723-6","volume":"20","author":"JL Dikken","year":"2013","unstructured":"Dikken JL, Baser RE, Gonen M et al (2013) Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer. Ann Surg Oncol 20:1623\u20131630","journal-title":"Ann Surg Oncol"},{"key":"1869_CR19","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/cam4.3876","volume":"10","author":"YW Zhou","year":"2021","unstructured":"Zhou YW, Long YX, Chen Y et al (2021) First-line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component. Cancer Med 10:3388\u20133402","journal-title":"Cancer Med"},{"key":"1869_CR20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/annonc\/mdr062","volume":"23","author":"V Catalano","year":"2012","unstructured":"Catalano V, Loupakis F, Graziano F et al (2012) Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer. Ann Oncol 23:135\u2013141","journal-title":"Ann Oncol"},{"key":"1869_CR21","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1245\/s10434-014-4159-7","volume":"22","author":"K Inamura","year":"2015","unstructured":"Inamura K, Yamauchi M, Nishihara R et al (2015) Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma. Ann Surg Oncol 22:1226\u20131235","journal-title":"Ann Surg Oncol"},{"key":"1869_CR22","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1245\/s10434-012-2321-7","volume":"19","author":"JR Hyngstrom","year":"2012","unstructured":"Hyngstrom JR, Hu CY, Xing Y et al (2012) Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base. Ann Surg Oncol 19:2814\u20132821","journal-title":"Ann Surg Oncol"},{"key":"1869_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejca.2011.12.004","volume":"48","author":"LJ Mekenkamp","year":"2012","unstructured":"Mekenkamp LJ, Heesterbeek KJ, Koopman M et al (2012) Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer. Eur J Cancer 48:501\u2013509","journal-title":"Eur J Cancer"},{"key":"1869_CR24","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/DCR.0000000000001060","volume":"61","author":"BG Soliman","year":"2018","unstructured":"Soliman BG, Karagkounis G, Church JM et al (2018) Mucinous histology signifies poor oncologic outcome in young patients with colorectal cancer. Dis Colon Rectum 61:547\u2013553","journal-title":"Dis Colon Rectum"},{"key":"1869_CR25","doi-asserted-by":"crossref","unstructured":"Kim CW, Cha JM, Kwak MS (2021) Identification of potential biomarkers and biological pathways for poor clinical outcome in mucinous colorectal adenocarcinoma. Cancers (Basel) 13:3280","DOI":"10.3390\/cancers13133280"},{"key":"1869_CR26","doi-asserted-by":"crossref","unstructured":"Dong B, Chen Y, Lyu G (2022) Prognostic nomograms for predicting overall survival and cancer-specific survival of patients with very early onset colorectal cancer: a population\u2011based analysis. Bosn J Basic Med Sci 22:803-817","DOI":"10.17305\/bjbms.2021.7035"},{"key":"1869_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/PAS.0b013e31822d3008","volume":"36","author":"V Barresi","year":"2012","unstructured":"Barresi V, Reggiani Bonetti L, Vitarelli E et al (2012) Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases. Am J Surg Pathol 36:66\u201372","journal-title":"Am J Surg Pathol"},{"key":"1869_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s10549-017-4610-0","volume":"169","author":"AS Hamy","year":"2018","unstructured":"Hamy AS, Lam GT, Laas E et al (2018) Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma. Breast Cancer Res Treat 169:295\u2013304","journal-title":"Breast Cancer Res Treat"},{"key":"1869_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.21147\/j.issn.1000-9604.2019.05.08","volume":"31","author":"L Wu","year":"2019","unstructured":"Wu L, Liang Y, Zhang C et al (2019) Prognostic significance of lymphovascular infiltration in overall survival of gastric cancer patients after surgery with curative intent. Chin J Cancer Res 31:785\u2013796","journal-title":"Chin J Cancer Res"},{"key":"1869_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/DCR.0000000000001258","volume":"62","author":"M Skancke","year":"2019","unstructured":"Skancke M, Arnott SM, Amdur RL et al (2019) Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum 62:181\u2013188","journal-title":"Dis Colon Rectum"},{"key":"1869_CR31","first-page":"e148","volume":"275","author":"CF R\u00f6nnow","year":"2022","unstructured":"R\u00f6nnow CF, Arthursson V, Toth E et al (2022) Lymphovascular infiltration, not depth of invasion, is the critical risk factor of metastases in early colorectal cancer: retrospective population-based cohort study on prospectively collected data. Including Validation Ann Surg 275:e148\u2013e154","journal-title":"Including Validation Ann Surg"},{"key":"1869_CR32","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1080\/0284186X.2016.1230274","volume":"55","author":"M Nikberg","year":"2016","unstructured":"Nikberg M, Chabok A, Letocha H et al (2016) Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry. Acta Oncol 55:1418\u20131424","journal-title":"Acta Oncol"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01869-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01869-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T02:09:34Z","timestamp":1730945374000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01869-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01869-5","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"22 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Research involving human participants and\/or animals"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}